Evidence map›Paper›PMID 31546654›Full record

ReviewInternational journal of molecular sciences2019

The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.

Francesco Ingenito, Giuseppina Roscigno, Alessandra Affinito, Silvia Nuzzo, Iolanda Scognamiglio, Cristina Quintavalle, Gerolama Condorelli

Registry-linked trialAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06388967 (Early Detection of Pancreatic Cancer), which is not on this map. Cited by 97 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06388967 recruitingnot on this mapstarted 2023, after this paper: background citation

Early Detection of Pancreatic Cancer: Prospective Study

TypeobservationalSponsorCity of Hope Medical CenterRan2023 to 2030Enrolled2,000ConditionsPancreatic Cancer, Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Ductal AdenocarcinomaArmsPANcreatic cancer Exosome Early detectiON (PANXEON)
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. miR‑205: A dual regulator of angiogenesis in health and disease (Review).International journal of molecular medicine · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. LncRNA LINC00466 Promotes the Progression of Breast CancerCurrent pharmaceutical biotechnology · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francesco IngenitoPercuros BV, Albinusdreef 2 - 2333ZA Leiden, Percuros BV, Zernikedreef 8. 2333 CL Leiden, The Netherlands. francesco.ingenito@outlook.it.
Giuseppina RoscignoDepartment of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, Via Pansini 5, 80131 Naples, Italy. giusy_roscigno@yahoo.it.
Alessandra AffinitoPercuros BV, Albinusdreef 2 - 2333ZA Leiden, Percuros BV, Zernikedreef 8. 2333 CL Leiden, The Netherlands. a.affinito@percuros.com.
Silvia NuzzoIRCCS SDN, IT-80143 Naples, Italy. snuzzo@sdn-napoli.it.
Iolanda ScognamiglioDepartment of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, Via Pansini 5, 80131 Naples, Italy. Iolanda.scognamiglio@gmail.com.
Cristina QuintavallePercuros BV, Albinusdreef 2 - 2333ZA Leiden, Percuros BV, Zernikedreef 8. 2333 CL Leiden, The Netherlands. c.quintavalle@percuros.com.
Gerolama CondorelliDepartment of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, Via Pansini 5, 80131 Naples, Italy. gecondor@unina.it.

Funding

Associazione Italiana per la Ricerca sul Cancro IG 2013 N.14046Associazione Italiana per la Ricerca sul Cancro IG 2016 N. 8473European grant IF_MSCA n: 838988
6 · The paper itself

Abstract

Exosomes are extracellular vesicles released into biological fluids where they act as carriers of various molecules, including proteins, lipids, and RNAs, between cells, modulating or perturbing specific physiological processes. Recently, it has been suggested that tumoral cells release excessive amounts of exosomes that, through their cargo, promote tumor progression, stimulating growth, angiogenesis, metastasis, insensitivity to chemotherapy, and immune evasion. Increasing evidence highlights exosomal microRNAs (exo-miRNAs) as important players in tumorigenesis. MicroRNA (miRNA) are a class of small non-coding RNA able to regulate gene expression, targeting multiple mRNAs and inducing translational repression and/or mRNA degradation. Exo-miRNAs are highly stable and easily detectable in biological fluids, and for these reasons, miRNAs are potential cancer biomarkers useful diagnostically and prognostically. Furthermore, since exosomes are natural delivery systems between cells, they can be appropriately modified to carry therapeutic miRNAs to specific recipient cells. Here we summarize the main functions of exo-miRNAs and their possible role for diagnostic and therapeutic applications.

Indexed as

Biomarkers, TumorExosomesHumansMicroRNAsNeoplasmsPrognosisTumor MicroenvironmentBiomarkers, TumorMicroRNAsbrain tumorscancer diagnosiscancer therapyexosomemicroRNAtumor microenvironment

Identifiers

PMID31546654
PMCPMC6801421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.